Xencor, Inc.
ENGINEERED IL-2 Fc FUSION PROTEINS

Last updated:

Abstract:

The present invention provides IL-2-Fc fusion proteins comprising IL-2 variants.

Status:
Application
Type:

Utility

Filling date:

18 Jan 2022

Issue date:

7 Jul 2022